Fact CheckerSign in

NCT07117084Active, not recruiting

Imaging Markers of High-Risk Plaque Phenotype for Predicting Post-PCI Outcomes

Imaging Markers of High-Risk Plaque Phenotype for Predicting Post-PCI Outcomes (IMPACT-PCI) Study: A Multicenter Cohort Study Based on Coronary CT Angiography

Source: ClinicalTrials.gov · Last updated 12 Aug 2025

Brief summary (registry, in English)

Despite the widespread use of stents, previous studies have shown that stent implantation mainly relieves symptoms but may not significantly improve long-term outcomes in patients with stable coronary artery disease. Identifying the types of plaques that are most likely to benefit from stenting is essential for improving personalized treatment. This study explores whether coronary computed tomography angiography (CCTA)-derived imaging biomarkers of coronary plaques are associated with increased risk of adverse outcomes after percutaneous coronary intervention (PCI). Around 2,000 patients who underwent CCTA followed by stent placement were included. Advanced software was used to quantify plaque inflammation and composition. Findings from this research may help guide personalized treatment strategies in patients undergoing PCI.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
2000 (estimated)
First submitted
5 Aug 2025
Start date
1 Jan 2021
Primary completion date
31 Dec 2024
Lead sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
NCT number
NCT07117084

What you commit to

  • Study type: Observational
  • Planned participants: 2000
  • From 1 Jan 2021 to the primary completion date, 31 Dec 2024
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • elevated cardiac troponin levels within the 3 months preceding PCI;
  • history of coronary artery bypass grafting;
  • heart failure;
  • significant valvular heart disease;
  • refractory hypertension;

Other

  • patients whose PCI within 30 days after CCTA was performed on an emergency basis;
  • inadequate CCTA image quality;
  • balloon-only or mixed stent/balloon PCI strategies;
  • PCI for non-atherosclerotic lesions (e.g., in-stent restenosis, spontaneous coronary dissection);
  • non-ischemic cardiomyopathy;
  • persistent atrial fibrillation.

Who the study is looking for

  • patients aged 18 years or older;
  • patients who underwent clinically indicated PCI within 30 days following CCTA;
  • CCTA demonstrating the presence of coronary atherosclerotic plaque.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fuwai Hospital Chinese Academy of Medical Sciences
Coordinator of this site? Confirm its status
BeijingChinaUnknown status
Tai'an Central Hospital
Coordinator of this site? Confirm its status
Tai’anChinaUnknown status
Weifang People's Hospital
Coordinator of this site? Confirm its status
WeifangChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.